High materiality7/10
Sagimet Biosciences price target raised to $26 from $25 at Guggenheim
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises SGMT target to $26; current price is $9.37. Price has fallen about 2.45% since the signal.
- Guggenheim raises target to $26; price $9.37; -2.45% since signal.
Key facts
- 01
Target: $26
- 02
Posted price: $9.37
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.